← Evidence map

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment.

Brian P Epling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2022
2023
2024
2025
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 36200701